|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kleeff J, Korc M, Apte M, La Vecchia C,
Johnson CD, Biankin AV, Neale RE, Tempero M, Tuveson DA, Hruban RH,
et al: Pancreatic cancer. Nat Rev Dis Primers. 2:160222016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pelosi E, Castelli G and Testa U:
Pancreatic Cancer: Molecular Characterization, Clonal Evolution and
Cancer Stem Cells. Biomedicines. 5:652017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hruban RH, Pitman MB and Kimstra DS:
Tumors of the Pancreas, Afip Atlas of Tumor Pathology. (6th
edition). American Registry of Pathology. (Washington, DC).
1201–126. 2007.
|
|
5
|
Luo J, Chen XQ and Li P: The Role of TGF-β
and Its Receptors in Gastrointestinal Cancers. Transl Oncol.
12:475–484. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyazono K, Katsuno Y, Koinuma D, Ehata S
and Morikawa M: Intracellular and extracellular TGF-β signaling in
cancer: Some recent topics. Front Med. 12:387–411. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takagi K, Imura J, Shimomura A, Noguchi A,
Minamisaka T, Tanaka S, Nishida T, Hatta H and Nakajima T:
Establishment of highly invasive pancreatic cancer cell lines and
the expression of IL-32. Oncol Lett. 20:2888–2896. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nisticò P, Bissell MJ and Radisky DC:
Epithelial-mesenchymal transition: General principles and
pathological relevance with special emphasis on the role of matrix
metalloproteinases. Cold Spring Harb Perspect Biol. 4:42012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fuxe J, Vincent T and Garcia de Herreros
A: Transcriptional crosstalk between TGF-β and stem cell pathways
in tumor cell invasion: Role of EMT promoting Smad complexes. Cell
Cycle. 9:2363–2374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Wang S, Su J, Chu G, You H, Chen
Z, Sun H, Chen B and Zhou M: Interleukin-32α inactivates JAK2/STAT3
signaling and reverses interleukin-6-induced epithelial-mesenchymal
transition, invasion, and metastasis in pancreatic cancer cells.
OncoTargets Ther. 9:4225–4237. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nishida A, Andoh A, Inatomi O and Fujiyama
Y: Interleukin-32 expression in the pancreas. J Biol Chem.
284:17868–17876. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kyuno D, Takasawa A, Kikuchi S, Takemasa
I, Osanai M and Kojima T: Role of tight junctions in the
epithelial-to-mesenchymal transition of cancer cells. Biochim
Biophys Acta Biomembr. 1863:1835032021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Zhao S, Karnad A and Freeman JW:
The biology and role of CD44 in cancer progression: Therapeutic
implications. J Hematol Oncol. 11:642018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jacobson A and Cunningham JL: Connective
tissue growth factor in tumor pathogenesis. Fibrogenesis Tissue
Repair. 5 (Suppl 1):S82012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Scheau C, Badarau IA, Costache R, Caruntu
C, Mihai GL, Didilescu AC, Constantin C and Neagu M: The Role of
Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition
of Hepatocellular Carcinoma. Anal Cell Pathol (Amst).
2019:94239072019.PubMed/NCBI
|
|
16
|
Pukrop T, Klemm F, Hagemann T, Gradl D,
Schulz M, Siemes S, Trümper L and Binder C: Wnt 5a signaling is
critical for macrophage-induced invasion of breast cancer cell
lines. Proc Natl Acad Sci USA. 103:5454–5459. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Takeshita A, Iwai S, Morita Y,
Niki-Yonekawa A, Hamada M and Yura Y: Wnt5b promotes the cell
motility essential for metastasis of oral squamous cell carcinoma
through active Cdc42 and RhoA. Int J Oncol. 44:59–68. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Agnihotri N, Kumar S and Mehta K: Tissue
transglutaminase as a central mediator in inflammation-induced
progression of breast cancer. Breast Cancer Res. 15:2022013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ito T, Hayashida M, Kobayashi S, Muto N,
Hayashi A, Yoshimura T and Mori H: Serine racemase is involved in
d-aspartate biosynthesis. J Biochem. 160:345–353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee J, Kim KE, Cheon S, Song JH, Houh Y,
Kim TS, Gil M, Lee KJ, Kim S, Kim D, et al: Interleukin-32α induces
migration of human melanoma cells through downregulation of
E-cadherin. Oncotarget. 7:65825–65836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sloot YJE, Rabold K, Ulas T, De Graaf DM,
Heinhuis B, Händler K, Schultze JL, Netea MG, Smit JWA, Joosten
LAB, et al: Interplay between thyroid cancer cells and macrophages:
Effects on IL-32 mediated cell death and thyroid cancer cell
migration. Cell Oncol (Dordr). 42:691–703. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sloot YJE, Smit JW, Joosten LAB and
Netea-Maier RT: Insights into the role of IL-32 in cancer. Semin
Immunol. 38:24–32. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsai CY, Wang CS, Tsai MM, Chi HC, Cheng
WL, Tseng YH, Chen CY, Lin CD, Wu JI, Wang LH, et al:
Interleukin-32 increases human gastric cancer cell invasion
associated with tumor progression and metastasis. Clin Cancer Res.
20:2276–2288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yousif NG, Al-Amran FG, Hadi N, Lee J and
Adrienne J: Expression of IL-32 modulates NF-κB and p38 MAP kinase
pathways in human esophageal cancer. Cytokine. 61:223–227. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Hu Z, Li N and Jiang R:
Interleukin-32 stimulates osteosarcoma cell invasion and motility
via AKT pathway-mediated MMP-13 expression. Int J Mol Med.
35:1729–1733. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weinberg RA: The Biology of Cancer. (2nd
edition). Garland Science. (Cambridge, MA). 658–691. 2013.
|
|
28
|
Ikenouchi J, Matsuda M, Furuse M and
Tsukita S: Regulation of tight junctions during the
epithelium-mesenchyme transition: Direct repression of the gene
expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zeng Q, Li S, Zhou Y, Ou W, Cai X, Zhang
L, Huang W, Huang L and Wang Q: Interleukin-32 contributes to
invasion and metastasis of primary lung adenocarcinoma via
NF-kappaB induced matrix metalloproteinases 2 and 9 expression.
Cytokine. 65:24–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao WB, Wang QL, Xu YT, Xu SF, Qiu Y and
Zhu F: Overexpression of interleukin-32α promotes invasion by
modulating VEGF in hepatocellular carcinoma. Oncol Rep.
39:1155–1162. 2018.PubMed/NCBI
|
|
31
|
Klingbeil P, Marhaba R, Jung T, Kirmse R,
Ludwig T and Zöller M: CD44 variant isoforms promote metastasis
formation by a tumor cell-matrix cross-talk that supports adhesion
and apoptosis resistance. Mol Cancer Res. 7:168–179. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsai HC, Su HL, Huang CY, Fong YC, Hsu CJ
and Tang CH: Correction: CTGF increases matrix metalloproteinases
expression and subsequently promotes tumor metastasis in human
osteosarcoma through down-regulating miR-519d. Oncotarget.
11:4922020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Yu Z, Zhou Q, Wu X, Chen X, Li J,
Zhu Z, Liu B and Su L: Tissue transglutaminase-2 promotes gastric
cancer progression via the ERK1/2 pathway. Oncotarget. 7:7066–7079.
2016. View Article : Google Scholar : PubMed/NCBI
|
